
Radiation Oncology Resident @MoffittRadOnc // Husband + Girl Dad
Joined March 2020
- Tweets307
- Following705
- Followers563
- Likes631
Pinned Tweet
Extremely excited and proud to have matched at Moffitt Cancer Center!
Could not have done this without the support of my loving wife @katerinabryant, family, friends, and mentors!
Also looking forward to training with my good friend @rcruzchamorro
@MoffittRadOnc #RadOncMatch20
JM Bryant, MD retweeted
Congratulations to our Graduating Medical and Physics Residents! (Dr. Bryant, Dr. Cruz-Chamorro and Dr. Koo). We are so proud of you and know you will go onto great things! @JMBryantMD @RCruzChamorro @JessicaFrakesMD @EvanWuthrick @KOSJ12 @MoffittRadOnc @MoffittNews #radonc
JM Bryant, MD retweeted
Congratulations to our graduating chief residents for passing their clinical boards!! 🎉💯 @JMBryantMD @RCruzChamorro
JM Bryant, MD retweeted
This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.
JM Bryant, MD retweeted
This year, we received a record number of applications and interviewed an incredibly competitive group. We’re thrilled to announce our match class! #MatchDay2025 #RadOnc ⚡️☢️☀️🌊@SylvesterCancer @umiamimedicine @HenriFordMD @DrSDNimer
JM Bryant, MD retweeted
Thank you so much to Dr. Einhorn for being our honored guest at Resident Research Day ! Congrats to all the residents and their great presentations ! @MoffittRadOnc @MoffittNews @KOSJ12 @JessicaFrakesMD @JMBryantMD @RCruzChamorro #radonc
JM Bryant, MD retweeted
Patients can benefit from SBRT / PBT over TACE in HCC (ineligible for upfront surgery/transplant) !
🚨 Local Control HR 0.16 (0.08, 0.34) 🚨
💥 PFS HR 0.37 (0.23, 0.60) 💥
OS RR 0.79 (0.51, 1.22)
Toxicity RR 0.86 (0.31, 2.37)
JM Bryant, MD retweeted
Utilizing the HARD approach, we showed a 2 fold increase in 3y LC (96% vs 48%), along with a PFS benefit for non-metastatic patients!
@MoffittRadOnc @MoffittNews
#GoHardAtSoftTissueSarcoma
thegreenjournal.com/article/…
JM Bryant, MD retweeted
Going HARD at Soft Tissue Sarcoma!
thegreenjournal.com/article/…
JM Bryant, MD retweeted
As we enter the last week of pancreas cancer awareness month- I want to remind everyone that the status quo is NOT GOOD ENOUGH for our patients.
The only way we will make any progress is to design (& fund!) patient-centered clinical trials. Here are some I'm excited about 🧵:
JM Bryant, MD retweeted
Congratulations to @Naghavi_MD, @JMBryantMD, et al. for their HARD work and creating innovative and sophisticated solutions for patients with unresected soft-tissue sarcoma!
Hypofractionated accelerated radiation dose-painting (HARD) improves o... sciencedirect.com/science/ar…
JM Bryant, MD retweeted
Is preoperative SRS an option for brain metastases undergoing resection?
Proud to share the INTERNEO results- an international collaboration of neoadjuvant SRS @RO_GreenJournal
↘️ low rates of local recurrence, nodular LMD and radionecrosis (all <5% at 12 months)
🌍 Global experience: nine institutions across 5 countries 🇦🇺🇺🇸🇨🇭🇯🇵🇨🇦
⚡️⚡️⚡️High proportion multi-fraction SRS
⏱️Extended follow-up
Link: authors.elsevier.com/a/1k9iP…
@HaghighiNeda @PeterMacRadOnc
JM Bryant, MD retweeted
Utilizing the HARD technique for Unresected sarcomas showed a 2-fold increase in 3y LRC (96% v 48%), when compared to standard fractionated RT. Congrats to @JMBryantMD for acceptance in @RO_GreenJournal. @MoffittRadOnc @MoffittNews #greenjournal @RadiotherapyOn1 @QuadShotNews
Thanks @QuadShotNews for highlighting the HARD work by @JMBryantMD and @MNMillsMD
quadshotnews.com/hard-knocks…
#GoingHARDatSoftTissueSarcoma
@MoffittNews
@MoffittRadOnc
JM Bryant, MD retweeted
🧬Urinary extracellular vesicle miRNAs to detect pancreatic cancer
@eClinicalMed
✅Sensitivity (training and test sets)
All: 93.9% and 77.8%
Stage I/IIA: 97% and 77.8%
✅Outperformed ca19-9
⁉️A noninvasive urinary assay
👉doi.org/10.1016/j.eclinm.202…
@TheLancetOncol @TheLancet @OncoAlert @Aiims1742 #cancer #oncology #MedX
JM Bryant, MD retweeted
Dr Eric Tseng from @Sunnybrook @UofTDRO presenting the UNITED trial @mr_linac meeting in Singapore. Radiation exposure to normal brain can be minimized without compromising control for glioblastoma using online adaptive radiotherapy on the MR-Linac
JM Bryant, MD retweeted
Congratulations to @JacqAndreozzi on winning the ARRO educator of the year award, @NakashimaJustyn on winning the clinical award, and to @JMBryantMD on winning the leadership award! 💪🏽💥@JessicaFrakesMD @SA_Rosenberg
JM Bryant, MD retweeted
At 2 years, the FFBR rate was 90.3% among patients who received nivolumab plus radiotherapy compared with a historical control rate of 75% (P = .025). #pcsm | @ASTRO_org @JMBryantMD
cancernetwork.com/view/nivol…
JM Bryant, MD retweeted
Nivolumab Plus Radiotherapy Reduces Rates of Biochemical Recurrence in Gleason Grade 5 Prostate Cancer @JMBryantMD @MoffittRadOnc @ASTRO_org #pcsm #oncology #ASTRO24
onclive.com/view/nivolumab-p…
JM Bryant, MD retweeted
The addition of nivolumab to SOC was associated with an improvement in freedom from biochemical recurrence in patients with grade group 5 prostate cancer, according to data from a phase 2 study presented at #ASTRO24. | @JMBryantMD #pcsm
urologytimes.com/view/nivolu…
JM Bryant, MD retweeted
Moffitt study presented at #ASTRO24 shows promising results for treating aggressive prostate cancer with #immunotherapy.
#MoffittASTRO24 @ASTRO_org @JMBryantMD
bit.ly/3Y4QSym










































